JP2002171966A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002171966A5 JP2002171966A5 JP2000368287A JP2000368287A JP2002171966A5 JP 2002171966 A5 JP2002171966 A5 JP 2002171966A5 JP 2000368287 A JP2000368287 A JP 2000368287A JP 2000368287 A JP2000368287 A JP 2000368287A JP 2002171966 A5 JP2002171966 A5 JP 2002171966A5
- Authority
- JP
- Japan
- Prior art keywords
- cord blood
- interleukin
- antibody
- derived
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004698 lymphocyte Anatomy 0.000 description 8
- 210000004700 fetal blood Anatomy 0.000 description 7
- 208000035473 Communicable disease Diseases 0.000 description 5
- 102000000588 Interleukin-2 Human genes 0.000 description 5
- 108010002350 Interleukin-2 Proteins 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 3
- 210000005087 mononuclear cell Anatomy 0.000 description 3
- 238000012258 culturing Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 241000695274 Processa Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000368287A JP4917201B2 (ja) | 2000-12-04 | 2000-12-04 | 臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤、臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤、臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤ならびに臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤の製造方法。 |
| EP01310091A EP1211311A3 (en) | 2000-12-04 | 2001-12-03 | Cord blood-derived activated lymphocytes and preparations containing said lymphocytes |
| CN01140404A CN1363681A (zh) | 2000-12-04 | 2001-12-04 | 源于脐带血的活化淋巴细胞、含有所述淋巴细胞作为主要成分的制剂和制备所述制剂的方法与成套器具 |
| US10/003,539 US6692958B2 (en) | 2000-12-04 | 2001-12-04 | Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000368287A JP4917201B2 (ja) | 2000-12-04 | 2000-12-04 | 臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤、臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤、臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤ならびに臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤の製造方法。 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002171966A JP2002171966A (ja) | 2002-06-18 |
| JP2002171966A5 true JP2002171966A5 (enExample) | 2008-01-17 |
| JP4917201B2 JP4917201B2 (ja) | 2012-04-18 |
Family
ID=18838567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000368287A Expired - Fee Related JP4917201B2 (ja) | 2000-12-04 | 2000-12-04 | 臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤、臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤、臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤ならびに臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤の製造方法。 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US6692958B2 (enExample) |
| EP (1) | EP1211311A3 (enExample) |
| JP (1) | JP4917201B2 (enExample) |
| CN (1) | CN1363681A (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7572631B2 (en) | 2000-02-24 | 2009-08-11 | Invitrogen Corporation | Activation and expansion of T cells |
| JP4562353B2 (ja) * | 2002-04-08 | 2010-10-13 | 株式会社リンフォテック | Ｈｌａ一致他人由来活性化リンパ球を含有してなる腫瘍・感染症および自己免疫疾患の予防・治療用製剤 |
| US20070025961A1 (en) | 2003-06-03 | 2007-02-01 | Kenzo Bamba | Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf |
| WO2005090977A1 (en) | 2004-03-12 | 2005-09-29 | Exelixis, Inc | C20orf23 as modifier of the igfr pathway and methods of use |
| US20080267972A1 (en) * | 2005-02-10 | 2008-10-30 | Invitrogen Corporation | Donor Lymphocyte Infusion of T Cells For the Treatment of Cancer |
| JP2007055906A (ja) * | 2005-08-22 | 2007-03-08 | Lymphotec:Kk | 腫瘍犬の治療法、その治療用製剤、腫瘍犬治療用細胞の凍結保存方法 |
| RU2462511C2 (ru) * | 2006-08-01 | 2012-09-27 | Ариджен Фармасьютикалз, Инк. | Способ пролиферации клеток lak |
| JP5596007B2 (ja) * | 2011-12-09 | 2014-09-24 | 保幸 黒岩 | 細胞培養方法および培養装置 |
| JP6142142B2 (ja) * | 2012-04-10 | 2017-06-07 | 株式会社リンフォテック | メモリーｔ細胞を主成分とするリンパ球細胞群の製造方法 |
| CN113952475B (zh) * | 2021-09-27 | 2025-03-11 | 中国人民解放军陆军军医大学 | 淋巴细胞和介导crispr系统的纳米复合物联合在制备治疗宫颈癌药物中的应用 |
| CN114438027A (zh) * | 2022-02-28 | 2022-05-06 | 浙江卫未生物医药科技有限公司 | 一种脐带血淋巴细胞制剂的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1001034B (el) * | 1989-07-21 | 1993-03-31 | Ortho Pharma Corp | Μεθοδος διεγερσης του πολλαπλασιασμου λεμφοκυτταρων περιφερειακου αιματος. |
| IL112969A (en) * | 1994-03-17 | 2001-05-20 | Baxter Int | Pharmaceutical compositions for the treatment of cancer comprising allogenic lymphocytes or their combination with a t-cell activator |
| US5773224A (en) * | 1996-02-12 | 1998-06-30 | Grandics; Peter | Immunoselection system for cell elution |
| DE69738997D1 (de) * | 1996-07-15 | 2008-10-30 | Lymphotec Inc | Mittel zur heilung bzw. vorbeugung viraler infektionen, verfahren zu deren herstellung sowie verfahren zur vorbeugung bzw. heilung viraler infektionen |
| JP4389039B2 (ja) * | 1998-04-09 | 2009-12-24 | 株式会社リンフォテック | アロジェニックな活性化ｃｄ４陽性細胞を主成分とする医薬組成物、およびその製造方法、ならびに該医薬組成物調製用キット |
-
2000
- 2000-12-04 JP JP2000368287A patent/JP4917201B2/ja not_active Expired - Fee Related
-
2001
- 2001-12-03 EP EP01310091A patent/EP1211311A3/en not_active Ceased
- 2001-12-04 US US10/003,539 patent/US6692958B2/en not_active Expired - Lifetime
- 2001-12-04 CN CN01140404A patent/CN1363681A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002506831A5 (enExample) | ||
| JP2004506598A5 (enExample) | ||
| JP2002171966A5 (enExample) | ||
| JP2003514523A5 (enExample) | ||
| JP2002501748A5 (enExample) | ||
| NZ597965A (en) | Methods of preparing and using stem cell compositions and kits comprising the same | |
| CN106967674B (zh) | 一种绵羊瘤胃上皮细胞的分离培养方法 | |
| CA2392075A1 (en) | Method for the preparation of purified hcv rna by exosome separation | |
| JP2001524307A5 (enExample) | ||
| WO2002036141A3 (en) | Method of enhancing lymphocyte-mediated immune responses | |
| CN107254439A (zh) | 增强自然杀伤细胞增殖和活性的方法 | |
| WO2002064748A8 (en) | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof | |
| CN108004209A (zh) | 一种脐血调节性t细胞体外扩增方法 | |
| EP1476540A1 (fr) | Procedes de production de lymphocytes gamma delta t | |
| JP2005519591A5 (enExample) | ||
| CN109646458B (zh) | 使用胎盘间充质干细胞制剂治疗硬化病的方法 | |
| WO2000050048A3 (en) | Bone marrow transplantation for hepatic regeneration and repair | |
| Roberts et al. | Effector mechanisms in allograft rejection I. Assembly of “sponge matrix” allografts | |
| WO2004099395A3 (en) | A method for the generation of neural progenitor cells | |
| RU2006126332A (ru) | Способ выделения клеток из секрета молочной железы | |
| EP1211311A3 (en) | Cord blood-derived activated lymphocytes and preparations containing said lymphocytes | |
| EP0953351A3 (en) | Medicaments containing, as the main ingredient, allogenic activated-CD4+ cells and method for producing the same | |
| WO2007030820A3 (en) | Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists | |
| EP0460065A1 (en) | A process for the generation of proliferating cd4 lymphocytes. | |
| Schuler et al. | Production and properties of large numbers of dendritic cells from human blood |